Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis.
The study involved 104 infants, children and young adults with advanced neuroblastoma, a cancer of the sympathetic nervous system. Investigators discovered the ATRX gene was mutated only in patients age 5 and older. The alterations occurred most often in patients age 12 and older. These older patients were also more likely than their younger counterparts to have a chronic form of neuroblastoma and die years after their disease is diagnosed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52992-st-jude-pediatric-cancer-genome-project-neuroblastoma-research
Adults aren’t the only ones who should be thinking heart smart this February, as heart disease is a concern for an increasing number of children, too. Research shows that overweight kids are more likely to develop heart disease as adults. And many overweight children already have conditions like high blood pressure and high cholesterol, which puts them at risk for heart disease now.
The good news is that most kids can address these risks with changes in diet and exercise. Throughout February, which is American Heart Month, BeSmartBeWell.com highlights the heart risks facing overweight kids and provides advice for how to manage them.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/childhoodobesity/50830/
Mimi’s Cafe Goes Red. Starting in February, American Heart Month, Mimi’s Cafe is giving a piece of its heart to the American Heart Association’s Go Red For Women movement. The neighborhood bistro inspired by France is the first-ever restaurant to nationally support the effort. Go Red For Women is dedicated to fighting heart disease, the number one killer of women, and harnessing the energy, passion and power women have to band together and collectively wipe out the disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54331-mimi-s-cafe-american-heart-association-go-red-for-women-heart-month
http://www.miraclemulti.com MiracleMulti™ The Best Multivitamins on the market for Men, Women, Vegetarians, and Bodybuilding. Once a day Multivitamin for Health, Energy, Focus, Well Being and Anti-aging.***These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Northwestern Mutual’s latest Cost of Long-Term Care study, released today, reveals consistently high costs for home health care, assisted living and nursing home care across the nation, underscoring the critical need to address long-term care as part of financial security planning.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53641-northwestern-mutual-cost-of-long-term-care-study-caregiving
Pregnancy is an exciting time filled with hopeful anticipation, and most pregnancies are uneventful and result in healthy babies. Pregnancy, however, is not entirely without risk, leading some expectant parents to worry about birth defects and whether they’ll give birth to a healthy baby.
Many birth defects are minor and easily treated. But about one in every 33 babies is born with a major birth defect, according to the Centers for Disease Control. Major birth defects may have a serious impact on development, functional ability and overall health. Throughout January, which is Birth Defects Prevention Month, BeSmartBeWell.com highlights pregnancy risks and preventable birth defects. At BeSmartBeWell.com medical experts, and real-life expectant moms, like Sharon, share information to help lower the risk for birth defects.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/birthdefects/50829/
Doctors at Children’s Hospital Boston are just another step closer to securing a cure for sickle cell disease thanks to a little help from some superstar friends. More than $1 million was raised in support of their research efforts on Sunday, January 15 during the “Play Without Pain: Children’s Sickle Cell Benefit,” a partnership with international megastar Celine Dion, Caesars Entertainment, AEG Live and Children’s Hospital Boston. Held at Caesars Palace, the evening included a performance of Celine Dion’s glamorous show directed by Grammy Awards producer Ken Ehrlich, including a touching tribute to sickle cell victims during her rendition of Billy Joel’s “Lullabye.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/54153-celine-dion-play-without-pain-children-s-sickle-cell-benefit
Health leaders around the world today will acknowledge an important achievement in the fight against polio as India marks one year since the last recorded case of wild poliovirus in the country.
This success is the result of the Government of India’s hard work and great partnerships with Rotary International, Centers for Disease Control and Prevention, WHO and UNICEF as well as millions of volunteers, health workers and community leaders.
To view Multimedia News Release, go to http://www.multivu.com/mnr/49366-gates-foundation-commends-india-on-one-year-polio-free
As the season turns from fall to winter, many holiday displays replace pop-up flu vaccine clinics. Yet flu season is not over — it has barely begun. In the 35 years that the Centers for Disease Control and Prevention (CDC) has monitored influenza, February has been the most common month for peak flu activity, including during the 2010-2011 flu season. To share this important information and educate families around the country, Families Fighting Flu is joining the CDC once again during the annual National Influenza Vaccination Week (NIVW) — an observance to promote the importance of flu vaccination as the single best preventative measure against this disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52236-families-fighting-flu-psa-flu-survivor-luke-duvall-flu-prevention
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced plans to launch its new epilepsy-focused educational website, www.Epilog.us, at the American Epilepsy Society (AES) annual meeting, December 3-5, 2011. The new website will be featured at the Upsher-Smith booth (# 102) and marks an important landmark in the Company’s commitment to the epilepsy community.
To view Multimedia News Release go to http://www.multivu.com/mnr/53440-upsher-smith-launches-new-epilepsy-focused-website
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43510-boston-scientific-fda-promus-element-plus-platinum-chromium-stent-system
